74-year-old patient remains recurrence-free 10 years after proton therapy for rectal cancer.

Elderly patients with colorectal cancer often present with multiple underlying conditions—such as diabetes, chronic kidney disease, cardiovascular disease, or pulmonary disease—or may suffer from concurrent malignancies. While surgery is the standard treatment for colorectal cancer, elderly patients undergoing surgery face challenges such as incomplete tumor resection and limited therapeutic efficacy. Open surgery further elevates clinical risks and significantly increases mortality rates in this population, with overall survival declining exponentially as age increases.

Liver metastasis occurs in 50%–60% of colorectal cancer patients, with over one-third of these cases involving patients aged 70 or older. Consequently, selecting appropriate treatment strategies for elderly patients is of great clinical importance, and identifying safe, effective therapies remains a key research focus for oncology experts.

Radiotherapy is a standard treatment modality for rectal cancer. By utilizing radiation for local tumor control, it has become a core component of cancer care, with its clinical value steadily increasing. However, conventional radiotherapy often causes significant toxic side effects in surrounding vital organs while targeting the tumor. Proton therapy has been proven in various clinical applications to deliver an equivalent radiation dose to the tumor while offering superior protection to surrounding healthy tissues and organs.
In the context of rectal cancer, proton therapy reduces the radiation dose received by adjacent organs at risk (OARs) while maintaining excellent target coverage and dose uniformity, demonstrating overall superiority over conventional radiotherapy techniques.

Elderly Case 1-Recurrent Rectal Cancer in an 85-Year-Old Patient—Significant Tumor Regression After Proton Therapy

A Japanese study published in *Cancer & Chemotherapy* documented a clinical case involving proton therapy for recurrent rectal cancer in an elderly patient.

The patient was an 85-year-old male who had previously undergone curative surgery for rectal and sigmoid colon cancer. Four years and two months post-surgery, he developed liver metastases in segments S3 and S8; both lesions were subsequently resected surgically. Eight years and six months after the initial surgery, a CT scan detected a solitary lymph node metastasis measuring 28 mm.
Given the lesion’s location and the patient’s advanced age and physical condition, the clinical team opted against surgery and chemotherapy in favor of proton therapy. The total treatment dose was 67.5 GyE, delivered in 25 fractions.

A follow-up CT scan four months after the completion of proton therapy showed partial remission, with the tumor shrinking to 8 mm. This state of remission persisted for two years and one month, with no treatment-related adverse effects or discomfort reported throughout the period. The research team concluded that proton therapy significantly reduces treatment toxicity, making it suitable for patients with complex tumor locations and fragile physical health.

Elderly Case Study 2-Locally Advanced Rectal Cancer in a 74-Year-Old Patient—Tumor Eradication and Long-Term Remission via Proton Therapy

A case study published in the *Clinical Journal of Gastroenterology* demonstrates the long-term efficacy of proton therapy for rectal cancer.

A 74-year-old female patient presented with rectal bleeding; a colonoscopy revealed a 30 mm locally advanced tumor near the anus. Curative surgery would have required an abdominoperineal resection and a permanent stoma. The patient declined this surgical option and instead chose proton therapy, receiving a total dose of 70.4 Gy.
Post-treatment colonoscopy confirmed tumor eradication, and follow-up spanning over a decade showed no signs of recurrence.

Rectal cancer is highly prevalent among the elderly, with incidence and mortality rates continuing to rise; elderly patients often present with multiple comorbidities, resulting in higher surgical risks. Clinical management for elderly rectal cancer patients must consider not only survival time but also quality of life and the ability to perform daily activities. Comprehensive assessment of efficacy and quality of life indicates that radiotherapy is a suitable option for this demographic. As a cutting-edge radiotherapy technique, proton therapy ensures effective anti-tumor outcomes while significantly reducing the risk of toxic side effects, making it a preferred treatment choice for elderly patients with rectal cancer.

Leave a reply